Psychiatry and Neurology, Neurology · Fairfield, CT
NPI
1831131176
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
75 Kings Highway Cutoff, 5th Floor
Fairfield, CT, 06824
Phone (203) 333-1133
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
4,397 services
Medicare patients, 2024
120
Average age 72
Drug cost, 2024
$761K
1,986 prescriptions
Company payments, 2025
$45K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by P. Christopher Gottschalk was code 99214 (office e&m - established), 74 times for 59 patients. In total P. Christopher Gottschalk billed 4,397 services in 26 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 74 | 59 | $97.67 | $7,228 |
| 99204 Office E&M - New | Office | 20 | 20 | $127.73 | $2,555 |
| 99213 Office E&M - Established | Office | 17 | 15 | $69.38 | $1,179 |
By year: 2022 $27K for 2,207 services; 2023 $32K for 3,192 services; 2024 $39K for 4,397 services.
Medicare prescription drug claims, 2024
In 2024, the drug P. Christopher Gottschalk prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 238 prescriptions and refills. In total P. Christopher Gottschalk wrote 1,986 Medicare prescriptions that cost $761K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 238 | 242 | 36 | $175K |
| Sumatriptan Succinate Generic | 142 | 165 | 35 | $25K |
| Rizatriptan Rizatriptan Benzoate | 136 | 149 | 37 | $1,959 |
| Topiramate Generic | 128 | 278 | 38 | $1,200 |
| Naratriptan Hcl Generic | 90 | 95 | 34 | $2,734 |
| Aimovig Autoinjector Erenumab-Aooe | 85 | 112 | 15 | $83K |
| Gabapentin Generic | 81 | 177 | 20 | $2,358 |
| Qulipta Atogepant | 60 | 70 | 17 | $74K |
| Metoclopramide Hcl Generic | 57 | 66 | 29 | $185 |
| Baclofen Generic | 51 | 87 | 14 | $1,495 |
| Eletriptan Hbr Eletriptan Hydrobromide | 51 | 53 | 12 | $2,434 |
| Pregabalin Generic | 49 | 73 | Under 11 | $2,091 |
| Nurtec Odt Rimegepant Sulfate | 46 | 46 | 14 | $57K |
| Oxcarbazepine Generic | 43 | 66 | 12 | $1,912 |
| Ubrelvy Ubrogepant | 40 | 42 | 15 | $54K |
Brand drugs: 591 claims; generic drugs: 1,395 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid P. Christopher Gottschalk $45K ($45K in general payments such as food, travel and fees) from 7 companies. The largest payer was H. Lundbeck A S with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.